NovoCure Ltd (NVCR): Shareholders' Equity
$340.47M
As of 2025-12-31
$338.09M
As of 2026-06-30
-8.3%
3-year compound annual growth
-6.5%
5-year compound annual growth
+3.1%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $340.47M | -5.5% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $360.18M | -0.6% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $362.50M | -17.8% | 2026-02-26, Balance as of period end |
| 2022-12-31 | $441.17M | +7.5% | 2025-02-27, Balance as of period end |
| 2021-12-31 | $410.49M | -13.9% | 2024-02-22, Balance as of period end |
| 2020-12-31 | $476.53M | +118.8% | 2023-02-23, Balance as of period end |
| 2019-12-31 | $217.79M | +94.0% | 2022-02-24, Balance as of period end |
| 2018-12-31 | $112.26M | -1.1% | 2021-02-25, Balance as of period end |
| 2017-12-31 | $113.56M | -20.2% | 2020-02-27, Balance as of period end |
| 2016-12-31 | $142.34M | -43.2% | 2019-02-28, Balance as of period end |
| 2015-12-31 | $250.82M | +156.3% | 2018-02-22, Balance as of period end |
| 2014-12-31 | $97.88M | -43.0% | 2017-02-23, Balance as of period end |
| 2013-12-31 | $171.78M | n/a | 2016-03-01, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| NovoCure Ltd (NVCR) | 2025-12-31 | $340.47M | -5.5% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $423.88M | +23.7% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $152.75M | +68.0% |
| Bioventus Inc. (BVS) | 2025-12-31 | $184.10M | +24.4% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $12.43M | n/m |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $491.94M | +6.7% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $450.04M | -10.6% |
| Glaukos Corp (GKOS) | 2025-12-31 | $656.15M | -14.4% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $781.16M | +13.3% |
Compare NVCR, UFPT, IRTC, BVS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗